$1.05 Billion is the total value of Redmile Group, LLC's 54 reported holdings in Q2 2016. The portfolio turnover from Q1 2016 to Q2 2016 was 48.9% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ARRY | ARRAY BIOPHARMA INC | $68,176,000 | +20.7% | 19,150,650 | 0.0% | 6.51% | +12.6% | |
| FOLD | Buy | AMICUS THERAPEUTICS INC | $60,641,000 | -33.0% | 11,106,446 | +3.6% | 5.79% | -37.5% |
| MDVN | Sell | MEDIVATION INC | $56,051,000 | -31.8% | 929,529 | -48.0% | 5.35% | -36.3% |
| SGEN | Buy | SEATTLE GENETICS INC | $55,825,000 | +64.0% | 1,381,477 | +42.4% | 5.33% | +53.0% |
| ATRA | Buy | ATARA BIOTHERAPEUTICS INC | $54,226,000 | +25.2% | 2,408,970 | +5.9% | 5.18% | +16.9% |
| PEN | Sell | PENUMBRA INC | $51,383,000 | -11.9% | 863,581 | -31.9% | 4.91% | -17.8% |
| ELGX | Buy | ENDOLOGIX INC | $49,376,000 | +139.2% | 3,962,753 | +60.5% | 4.72% | +123.3% |
| CLVS | Sell | CLOVIS ONCOLOGY INC | $42,503,000 | -28.6% | 3,097,850 | -0.0% | 4.06% | -33.3% |
| MOH | Buy | MOLINA HEALTHCARE INC | $42,183,000 | +98.8% | 845,360 | +156.9% | 4.03% | +85.5% |
| ITCI | Sell | INTRA CELLULAR THERAPIES INC | $37,716,000 | +28.5% | 971,565 | -8.0% | 3.60% | +19.9% |
| PTLA | Buy | PORTOLA PHARMACEUTICALS INC | $34,610,000 | +90.7% | 1,466,537 | +64.9% | 3.31% | +78.0% |
| NVRO | Buy | NEVRO CORP | $29,384,000 | +300.0% | 398,371 | +205.1% | 2.81% | +273.3% |
| BSX | Sell | BOSTON SCIENTIFIC CORP | $28,753,000 | +14.7% | 1,230,320 | -7.7% | 2.75% | +7.1% |
| XBI | New | SPDR SERIES TRUSTs&p biotech | $26,553,000 | – | 490,900 | +100.0% | 2.54% | – |
| MODN | Buy | MODEL N INC | $25,374,000 | +25.0% | 1,900,659 | +0.8% | 2.42% | +16.7% |
| BMRN | Sell | BIOMARIN PHARMACEUTICAL INC | $25,082,000 | -36.4% | 322,394 | -32.6% | 2.40% | -40.6% |
| NSTG | Buy | NANOSTRING TECHNOLOGIES INC | $24,560,000 | -13.4% | 1,949,185 | +4.6% | 2.35% | -19.2% |
| INCY | Buy | INCYTE CORP | $24,179,000 | +54.0% | 302,307 | +39.6% | 2.31% | +43.7% |
| BKD | Buy | BROOKDALE SR LIVING INC | $23,860,000 | +5.2% | 1,545,331 | +8.1% | 2.28% | -1.9% |
| ALXN | New | ALEXION PHARMACEUTICALS INC | $23,632,000 | – | 202,400 | +100.0% | 2.26% | – |
| HTWR | Buy | HEARTWARE INTL INC | $23,417,000 | +247.0% | 405,497 | +88.8% | 2.24% | +223.7% |
| WVE | Sell | WAVE LIFE SCIENCES LTD | $22,665,000 | +33.6% | 1,095,473 | -11.5% | 2.16% | +24.7% |
| AET | Sell | AETNA INC NEW | $22,377,000 | +3.9% | 183,225 | -4.4% | 2.14% | -3.0% |
| CNC | Sell | CENTENE CORP DEL | $20,351,000 | -29.8% | 285,143 | -39.4% | 1.94% | -34.4% |
| PRTA | New | PROTHENA CORP PLC | $17,040,000 | – | 487,406 | +100.0% | 1.63% | – |
| SYRS | New | SYROS PHARMACEUTICALS INC | $15,058,000 | – | 946,182 | +100.0% | 1.44% | – |
| Sell | NEURODERM LTD | $13,348,000 | -19.9% | 821,445 | -30.4% | 1.28% | -25.3% | |
| CMRX | New | CHIMERIX INC | $12,923,000 | – | 3,288,376 | +100.0% | 1.23% | – |
| OXFD | Buy | OXFORD IMMUNOTEC GLOBAL PLC | $12,853,000 | +48.0% | 1,428,094 | +63.0% | 1.23% | +38.1% |
| CRL | Buy | CHARLES RIV LABS INTL INC | $10,850,000 | +30.1% | 131,606 | +19.9% | 1.04% | +21.5% |
| ADPTQ | New | ADEPTUS HEALTH INCcl a | $8,445,000 | – | 163,474 | +100.0% | 0.81% | – |
| PGND | Sell | PRESS GANEY HLDGS INC | $7,800,000 | +18.8% | 198,214 | -9.2% | 0.74% | +10.9% |
| SPNC | New | SPECTRANETICS CORP | $7,518,000 | – | 401,836 | +100.0% | 0.72% | – |
| CTMX | Buy | CYTOMX THERAPEUTICS INC | $7,497,000 | -20.4% | 733,899 | +0.6% | 0.72% | -25.6% |
| CFMS | Buy | CONFORMIS INC | $7,356,000 | -13.6% | 1,047,821 | +32.2% | 0.70% | -19.4% |
| EVHC | New | ENVISION HEALTHCARE HLDGS IN | $7,330,000 | – | 288,918 | +100.0% | 0.70% | – |
| PMC | New | PHARMERICA CORP | $6,507,000 | – | 263,862 | +100.0% | 0.62% | – |
| WOOF | Sell | VCA INC | $6,369,000 | -46.9% | 94,200 | -54.7% | 0.61% | -50.4% |
| EHTH | Buy | EHEALTH INC | $5,976,000 | +50.9% | 426,242 | +1.1% | 0.57% | +41.0% |
| IRWD | Sell | IRONWOOD PHARMACEUTICALS INC | $5,788,000 | -87.8% | 442,711 | -89.8% | 0.55% | -88.6% |
| ARA | New | AMERICAN RENAL ASSOCIATES HO | $4,343,000 | – | 149,900 | +100.0% | 0.42% | – |
| NVTA | Sell | INVITAE CORP | $4,027,000 | -40.4% | 544,939 | -17.4% | 0.38% | -44.3% |
| ARRAY BIOPHARMA INCnote 3.000% 6/0 | $3,382,000 | +5.0% | 4,000,000 | 0.0% | 0.32% | -2.1% | ||
| PRQR | Buy | PROQR THRAPEUTICS N V | $2,815,000 | +4.4% | 581,638 | +5.2% | 0.27% | -2.5% |
| FATE | Buy | FATE THERAPEUTICS INC | $2,554,000 | -4.6% | 1,502,180 | +1.0% | 0.24% | -10.9% |
| SNDX | Sell | SYNDAX PHARMACEUTICALS INC | $2,471,000 | -29.5% | 250,830 | -4.6% | 0.24% | -34.3% |
| BPMC | Buy | BLUEPRINT MEDICINES CORP | $574,000 | +17.6% | 28,353 | +4.8% | 0.06% | +10.0% |
| AXGT | Buy | AXOVANT SCIENCES LTD | $321,000 | +179.1% | 25,000 | +150.0% | 0.03% | +158.3% |
| BIIB | New | BIOGEN INC | $297,000 | – | 1,229 | +100.0% | 0.03% | – |
| LHCG | New | LHC GROUP INC | $216,000 | – | 5,000 | +100.0% | 0.02% | – |
| TMH | New | TEAM HEALTH HOLDINGS INC | $203,000 | – | 5,000 | +100.0% | 0.02% | – |
| AUPH | Buy | AURINIA PHARMACEUTICALS INC | $79,000 | +36.2% | 28,410 | +44.1% | 0.01% | +33.3% |
| ADVM | New | ADVERUM BIOTECHNOLOGIES INC | $70,000 | – | 22,236 | +100.0% | 0.01% | – |
| CSLT | New | CASTLIGHT HEALTH INCcl b | $41,000 | – | 10,229 | +100.0% | 0.00% | – |
| CCXI | Exit | CHEMOCENTRYX INC | $0 | – | -10,000 | -100.0% | -0.00% | – |
| IHF | Exit | ISHARES TRus hlthcr pr etf | $0 | – | -4,520 | -100.0% | -0.06% | – |
| DRRX | Exit | DURECT CORP | $0 | – | -2,327,137 | -100.0% | -0.32% | – |
| PFE | Exit | PFIZER INC | $0 | – | -123,800 | -100.0% | -0.38% | – |
| GWPH | Exit | GW PHARMACEUTICALS PLCads | $0 | – | -82,300 | -100.0% | -0.61% | – |
| Exit | CLOVIS ONCOLOGY INCcall | $0 | – | -600,000 | -100.0% | -1.18% | – | |
| AGN | Exit | ALLERGAN PLC | $0 | – | -114,448 | -100.0% | -3.14% | – |
| SAGE | Exit | SAGE THERAPEUTICS INC | $0 | – | -1,053,018 | -100.0% | -3.46% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2016-08-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AMICUS THERAPEUTICS INC | 43 | Q3 2023 | 10.1% |
| ATARA BIOTHERAPEUTICS INC | 36 | Q3 2023 | 6.4% |
| FATE THERAPEUTICS INC | 34 | Q3 2023 | 17.2% |
| INVITAE CORP | 32 | Q3 2023 | 2.7% |
| REGENXBIO INC | 28 | Q3 2023 | 3.8% |
| CLOVIS ONCOLOGY INC | 27 | Q1 2020 | 6.7% |
| IMMUNOGEN INC | 27 | Q3 2023 | 13.2% |
| CASTLIGHT HEALTH INC SAN FRAN COM STK | 27 | Q1 2021 | 2.5% |
| ARRAY BIOPHARMA INC | 26 | Q2 2019 | 12.6% |
| DECIPHERA PHARMACEUTICALS IN | 25 | Q3 2023 | 7.0% |
View Redmile Group, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Neoleukin Therapeutics, Inc. | July 27, 2023 | 2,912,228 | 6.6% |
| IGM Biosciences, Inc. | June 28, 2023 | 3,291,092 | 9.9% |
| MedAvail Holdings, Inc. | June 21, 2023 | 124,507,268 | 73.1% |
| Achilles Therapeutics plc | February 14, 2023 | 1,608,089 | 3.9% |
| Kymera Therapeutics, Inc. | February 14, 2023 | 2,673,837 | 4.9% |
| Old Ayala, IncSold out | February 08, 2023 | 0 | 0.0% |
| Zymeworks Inc. | August 08, 2022 | 5,758,241 | 9.9% |
| Science 37 Holdings, Inc. | June 15, 2022 | 19,808,234 | 17.1% |
| Allakos Inc. | February 14, 2022 | 2,077,875 | 3.8% |
| Aprea Therapeutics, Inc.Sold out | February 14, 2022 | 0 | 0.0% |
View Redmile Group, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2024-04-01 |
| 4 | 2024-04-01 |
| 4 | 2024-03-25 |
| SC 13D/A | 2024-03-25 |
| 4 | 2024-03-19 |
| 4 | 2024-03-14 |
| 4 | 2024-03-13 |
| SC 13D/A | 2024-03-13 |
| 4 | 2024-03-05 |
| SC 13D/A | 2024-03-05 |
View Redmile Group, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.